OpGen Completes Rapid Testing Clinical Trial in Colombia and Expands International Operations

- April 19th, 2018

OpGen (NASDAQ:OPGN) OpGen announced today that it successfully completed a prospective clinical trial evaluating the impact of using rapid diagnostic testing for identification and treatment of bacteremia and fungemia in hospital intensive care units in Colombia. The study showed significant improvement in survival and reductions in antibiotic usage for patients receiving the OpGen rapid diagnostic … Continued

OpGen (NASDAQ:OPGN) OpGen announced today that it successfully completed a prospective clinical trial evaluating the impact of using rapid diagnostic testing for identification and treatment of bacteremia and fungemia in hospital intensive care units in Colombia. The study showed significant improvement in survival and reductions in antibiotic usage for patients receiving the OpGen rapid diagnostic test.  Results will be presented at the American Society for Microbiology ASM Microbe 2018 meeting this June.

As quoted in the press release:

The study was conducted with Maria Virginia Villegas, M.D., M.Sc., Bacteria Resistance and Hospital Epidemiology, Centro International de Entrenamiento e Investigationses Medicas (CIDEIM), Cali, Colombia and four Colombian acute care hospitals. Following the successful completion of the trial and positive hospital feedback, OpGen has established a subsidiary, OpGen Colombia, SAS, to commercialize OpGen’s precision medicine products in Colombia and more broadly through South America.

Evan Jones, OpGen Chairman and CEO, stated, “We were honored to be part of a regional prospective study demonstrating improved outcomes for patients with sepsis and other co-morbidities. We now have an established organization, leadership team and market data to support our growth initiative into South America.”

Click here to read the full press release.

  Life Science and Healthcare Investing in 2020 report cover

Life Science and Healthcare Investing in 2020

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2020 life science outlook report!
 

Leave a Reply